CFOs On the Move: Week Ending March 26
Condé Nast, Foot Locker, Velocity, Merck, DNA Script, Ibotta, Cano Health, Ring Energy, PG&E, Adobe
Foot Locker Shares Dive on Q2 Sales Miss
Same-store sales rose only 0.5% but the company remains confident it will deliver stronger growth in the second half of 2018.
Foot Locker Beats Estimates, Stock Climbs 26%
The struggling retailer's key metrics all declined in Q3 but Wall Street was expecting a "much more severe fall from grace."
Foot Locker Shares Dive on Big Earnings Miss
The company's CEO faults its suppliers for its Q2 results, saying there was "limited availability of innovative new products in the market."